InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Rajangam Kanya, Directeur Médical. Director active across 2 companies, notably Nkarta, Inc.. In total, 8 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €5k. History available since 5 August 2021. The latest transaction was disclosed on 9 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rajangam Kanya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
10,757 股0Common StockSEC:0001628280-26-016795:0
1,384 股0Common StockSEC:0001628280-26-005018:0
33,000 股@ US$2.2593.0% 占其流量Common StockSEC:0001854270-25-000034:0
78,363 股0Common StockSEC:0001854270-25-000015:0
1,297 股@ US$4.077.0% 占其流量Common StockSEC:0001854270-25-000002:0
101,000 股0Common StockSEC:0001854270-24-000017:0
12,800 股0Common StockSEC:0001209191-22-003756:0
10,000 股@ US$0.41100.0% 占其流量Common StockSEC:0000899243-21-032196:0
8 条申报中的 8 条
About Rajangam Kanya
Rajangam Kanya is Directeur Médical. He has 8 filings in total, and across the 8 sampled filings the transactions are mainly attributions, with EUR 5,111 of sales, over the period from 2021-08-09 to 2026-03-11. He is associated with Senti Biosciences, Inc. and Nkarta, Inc.
